Difference between revisions of "Part:BBa K4220008"
(→Results) |
|||
(17 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
The product coded by this sequence is used to show the position of P2Y2 and the function of P2A by mCherry reporter. | The product coded by this sequence is used to show the position of P2Y2 and the function of P2A by mCherry reporter. | ||
+ | |||
+ | *P2Y2 | ||
+ | **In order to increase its sensitivity and maximum response to sense eATP (extracellular ATP), we mutated K240N and F307S.[1] | ||
+ | |||
+ | *P2A | ||
+ | **After adding two proteins in the two sides of P2A, it will cleave by itself and release the two proteins at the same time. | ||
+ | |||
+ | *mCherry | ||
+ | **To report the successful cleavage of P2A peptide. | ||
==Results== | ==Results== | ||
− | 1.The P2A peptide can work effectively | + | 1.The P2A peptide can work effectively: |
+ | |||
+ | [[File:neu81.jpg|550px|options|caption]] | ||
+ | |||
− | + | 2.The production of P2Y2: | |
− | + | [[File:neu82.jpg|550px|options|caption]] | |
− | + | ==References== | |
+ | 1 Scott, B. M. et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nature Medicine 27, 1212-1222, doi:10.1038/s41591-021-01390-x (2021). | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 07:11, 1 October 2022
P2Y2-P2A-mCherry
Introduction
The product coded by this sequence is used to show the position of P2Y2 and the function of P2A by mCherry reporter.
- P2Y2
- In order to increase its sensitivity and maximum response to sense eATP (extracellular ATP), we mutated K240N and F307S.[1]
- P2A
- After adding two proteins in the two sides of P2A, it will cleave by itself and release the two proteins at the same time.
- mCherry
- To report the successful cleavage of P2A peptide.
Results
1.The P2A peptide can work effectively:
2.The production of P2Y2:
References
1 Scott, B. M. et al. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nature Medicine 27, 1212-1222, doi:10.1038/s41591-021-01390-x (2021).
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 1159
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 1095
Illegal AgeI site found at 389 - 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 570
Illegal SapI site found at 615